Mounjaro 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FAWKX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,216
Award facts
- Contract value 100% obligated
- $25,215.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,215.96 to DMS Pharmaceutical Group Inc. for the supply of Mounjaro 2.5 mg/0.5 mL pens on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order was issued without set-aside designation and represents performance in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the prime contractor for this delivery.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of federal contract awards covering an extensive array of medical products including prescription medications, biologics, and medical consumables. The company's consistent success in competing for DLA contracts demonstrates its capability to reliably deliver specialized pharmaceutical items to Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FAWKX?
SPE2DB25FAWKX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FAWKX worth?
The government has obligated $25,216 on SPE2DB25FAWKX.
Is contract SPE2DB25FAWKX an order under another contract?
Yes. SPE2DB25FAWKX is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWKX competed?
The extent of competition for SPE2DB25FAWKX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award